| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
21.15 |
% |
10.6019/CHEMBL4513141 |
| Bacillus subtilis |
Bacillus subtilis |
Activity |
nan |
None |
10.1016/j.bmcl.2014.07.070 |
| Bacillus subtilis |
Bacillus subtilis |
IZ |
22.0 |
mm |
10.1016/j.bmcl.2014.07.070 |
| Bacillus subtilis |
Bacillus subtilis |
IZ |
22.0 |
mm |
10.1016/j.ejmech.2012.12.061 |
| Bacillus subtilis |
Bacillus subtilis |
IZ |
25.0 |
mm |
10.1016/j.bmc.2010.03.019 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2010.03.019 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.061 |
| Bos taurus |
Dihydrofolate reductase |
IC50 |
22000.0 |
nM |
10.1016/j.bmc.2010.03.019 |
| Bos taurus |
Dihydrofolate reductase |
IC50 |
nan |
None |
10.1016/j.ejmech.2012.12.061 |
| Candida albicans |
Candida albicans |
Activity |
nan |
None |
10.1016/j.bmcl.2014.07.070 |
| Candida albicans |
Candida albicans |
Inhibition |
1.53 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
IZ |
25.0 |
mm |
10.1016/j.bmcl.2014.07.070 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
0.24 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1016/j.bmcl.2014.07.070 |
| Escherichia coli |
Escherichia coli |
Inhibition |
1.92 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
IZ |
18.0 |
mm |
10.1016/j.bmcl.2014.07.070 |
| Escherichia coli |
Escherichia coli |
IZ |
28.0 |
mm |
10.1016/j.ejmech.2012.12.061 |
| Escherichia coli |
Escherichia coli |
-Log C |
-0.52 |
None |
10.1021/jm00361a014 |
| Escherichia coli |
Escherichia coli |
-Log C |
3.248 |
None |
10.1021/jm00361a014 |
| Escherichia coli |
Escherichia coli |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.061 |
| Escherichia coli |
Escherichia coli |
MIC |
2000.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.03.008 |
| Escherichia coli |
Escherichia coli |
Ratio |
1.0 |
None |
10.1016/j.ejmech.2012.03.008 |
| Escherichia coli K-12 |
Dihydropteroate synthase |
GII50 |
3800.0 |
None |
10.1021/jm00136a015 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dihydrofolate reductase |
IC50 |
18000.0 |
nM |
10.1016/j.bmc.2010.03.019 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
1412.5 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-15.32 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.04 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Interleukin-8 |
Potency |
66824.2 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
500000.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
Inhibition |
80.0 |
% |
10.1021/jm301302s |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
TAR DNA-binding protein 43 |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
2818.4 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
11.67 |
% |
10.6019/CHEMBL4513141 |
| Micrococcus luteus |
Micrococcus luteus |
IZ |
18.0 |
mm |
10.1016/j.ejmech.2012.12.061 |
| Micrococcus luteus |
Micrococcus luteus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.061 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MBC |
256.0 |
ug ml-1 |
10.1016/j.bmc.2012.04.060 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
64.0 |
ug.mL-1 |
10.1016/j.bmc.2012.04.060 |
| Pasteurella multocida |
Pasteurella multocida |
IZ |
20.46 |
mm |
10.1016/j.bmcl.2006.11.001 |
| Pasteurella multocida |
Pasteurella multocida |
IZ |
21.22 |
mm |
10.1016/j.bmcl.2006.11.001 |
| Pasteurella multocida |
Pasteurella multocida |
IZ |
22.15 |
mm |
10.1016/j.bmcl.2006.11.001 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Activity |
nan |
None |
10.1016/j.bmcl.2014.07.070 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
6.24 |
% |
10.6019/CHEMBL4513141 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
IZ |
25.0 |
mm |
10.1016/j.ejmech.2012.12.061 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
IZ |
28.0 |
mm |
10.1016/j.bmcl.2014.07.070 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.061 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.66 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2126 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-3.73 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.23 |
% |
10.6019/CHEMBL4495565 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1016/j.bmcl.2014.07.070 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
13.64 |
% |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
20.0 |
mm |
10.1016/j.bmcl.2014.07.070 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
20.0 |
mm |
10.1016/j.ejmech.2012.12.061 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
28.0 |
mm |
10.1016/j.bmc.2010.03.019 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmc.2010.03.019 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.061 |
| None |
ADMET |
-Log alpha |
-3.15 |
None |
10.1021/jm00361a014 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
No relevant target |
Log K |
nan |
None |
10.1021/jm00361a014 |
| None |
No relevant target |
LogP |
-0.96 |
None |
10.1021/jm0611105 |
| None |
No relevant target |
pKa |
5.38 |
None |
10.1021/jm00136a015 |
| None |
No relevant target |
pKa |
5.78 |
None |
10.1021/jm00361a014 |
| None |
No relevant target |
pKa_A1 |
5.25 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
6470.0 |
ug.mL-1 |
10.1016/j.bmc.2010.08.003 |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
EII50 |
4.44 |
None |
10.1021/jm00136a015 |